Use Nektar Therapeutics historical price analysis together with your assets to protect against small markets fluctuations as well as to check it against diversification policy that fits your risk preferences.
The price series of Nektar for the period between Thu, Apr 26, 2012 and Sat, May 26, 2012 has a statistical range of 1.46 with a coefficient of variation of 4.89. The daily prices for the period are spread out with arithmetic mean of 7.1. The median price for the last 30 days is 7.1. The company underwent 2:1 stock split on August 23, 2000.
Date
Open
High
Low
Close
Volume
05/25/2012
7.02
7.02
6.85
6.96
615,000
05/24/2012
6.98
7.01
6.78
7.00
925,800
05/23/2012
6.62
7.01
6.61
6.97
1,300,000
05/22/2012
6.69
6.82
6.57
6.61
629,000
05/21/2012
6.45
6.71
6.42
6.70
792,100
05/18/2012
6.75
6.79
6.37
6.41
1,608,800
05/17/2012
7.04
7.13
6.74
6.75
1,084,200
05/16/2012
7.17
7.24
7.04
7.06
638,200
05/15/2012
7.21
7.30
7.11
7.17
589,200
05/14/2012
7.13
7.32
7.13
7.22
576,100
05/11/2012
7.07
7.29
7.03
7.22
788,600
05/10/2012
7.15
7.21
7.03
7.14
535,000
05/09/2012
7.12
7.18
7.03
7.10
569,500
05/08/2012
7.03
7.24
6.94
7.18
924,900
05/07/2012
6.90
7.16
6.89
7.06
900,100
05/04/2012
7.11
7.11
6.80
6.90
1,514,200
05/03/2012
7.78
7.79
7.02
7.13
2,353,400
05/02/2012
7.58
7.73
7.55
7.61
1,129,400
05/01/2012
7.65
7.84
7.51
7.60
810,800
04/30/2012
7.84
7.89
7.59
7.63
944,700
04/27/2012
7.83
7.90
7.70
7.87
815,700
04/26/2012
7.72
7.88
7.64
7.82
636,200
Discuss Nektar historical price analysis
Nektar Market Capitalization
Nektar Therapeutics is rated below average in market capitalization category among related companies. Market capitalization of Biotechnology industry is now estimated at about 212.36 Billion. Nektar adds roughly 797.69 Million in market capitalization claiming only tiny portion of stocks in Biotechnology industry.